"Every narcolepsy patient showed substantial loss of neurons in the locus coeruleus, with an average of 46% fewer norepinephrine-producing neurons compared to controls."
A study published in Nature Communications by UCLA Health researchers has found that narcolepsy with cataplexy involves degeneration of neurons in the hypothalamus and the locus coeruleus in the brainstem.
Key Findings
-
Researchers analyzed postmortem brain tissue from 11 individuals with narcolepsy with cataplexy and five neurologically healthy controls.
-
Every narcolepsy patient showed substantial loss of neurons in the locus coeruleus, with an average of 46% fewer norepinephrine-producing neurons compared to controls.
-
Surviving locus coeruleus neurons were about 18% larger than normal, suggesting compensatory activity.
-
Signs of neuroinflammation were found in the locus coeruleus, with microglial cells more than twice as numerous in narcolepsy patients.
-
Similar microglial clustering was observed around hypocretin neurons in the hypothalamus.
-
The cell loss appears to follow an immune-driven pathway rather than typical neurodegenerative patterns, as few protein deposits associated with Parkinson's or Alzheimer's were found.
-
Mouse and dog models of narcolepsy showed no reduction in locus coeruleus neurons, indicating the brainstem damage is a separate feature of human disease and not a downstream effect of hypocretin loss.
-
Deposits of tau and alpha-synuclein proteins were found in the locus coeruleus of narcolepsy patients, warranting further investigation.
Implications
The findings help explain why 15-30% of patients with narcolepsy with cataplexy have normal hypocretin levels.
Drugs that boost norepinephrine activity, such as reboxetine and solriamfetol, produce symptom relief, consistent with the role of the locus coeruleus.
The study suggests potential for earlier detection via biomarkers and development of more targeted therapies.
Background
Narcolepsy affects about 1 in 2,000 people. The severe form, narcolepsy type 1, includes cataplexy—sudden muscle weakness triggered by emotion. Previously, the condition was attributed solely to loss of hypocretin neurons in the hypothalamus.